Authors:
Carta, A
Sanna, P
Paglietti, G
Sparatore, F
Citation: A. Carta et al., C-13-NMR as useful tool for unambiguous identification of ring substitutedN-1(2)(3)-alkylbenzotriazole isomers, HETEROCYCLE, 55(6), 2001, pp. 1133-1140
Citation: P. Sanna et al., Synthesis of two novel tricyclic rings: Triazolo[4,5-g]quinolines and pyrido[2,3-g]quinoxalines derived from 6,7-diaminoquinolines, HETEROCYCLE, 53(2), 2000, pp. 423
Authors:
Corona, P
Vitale, G
Loriga, M
Paglietti, G
Citation: P. Corona et al., Quinoxaline chemistry. Part 13: 3-carboxy-2-benzylamino substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity, FARMACO, 55(2), 2000, pp. 77-86
Citation: P. Sanna et al., Triazolo[4,5-f]quinolines derived from 5-amino-(1H- and 2-methyl-2H)-benzotriazoles with beta-diketones and 3-buten-2-one, HETEROCYCLE, 51(9), 1999, pp. 2171-2181
Citation: P. Sanna et al., Synthesis of triazolo[4,5-f]quinolines. An unusual case of displacement ofnitro group in the reaction of 8-acetylamino-6-chloro-5-nitroquinoline with hydrazine and methylhydrazine, HETEROCYCLE, 50(2), 1999, pp. 693-702
Authors:
Vitale, G
Corona, P
Loriga, M
Paglietti, G
Citation: G. Vitale et al., Quinoxaline chemistry - Part 12. 3-carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity, FARMACO, 53(8-9), 1998, pp. 594-601